Relationship of Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 with Hypertensive Carotid Atherosclerosis in Elderly Patients
Qin Xing-han
Abstract
Qin Xing-han
Abstract
Objective To investigate the relationship of matrix metalloproteinase 9( MMP-9) and tissue inhibitor of metalloproteinase 1( TIMP-1) with hypertensive carotid atherosclerosis and its stability. Methods The intima-media thickness( IMT) was measured by using color Doppler ultrasound in 125 cases of hypertension. These patients were divided into simple hypertensive group( n =45),mild atherosclerosis group( n =42) and severe atherosclerosis group( n =38) according to the results of the ultrasound diagnosis. Based on the stability of plaque in atherosclerosis patients,they were classified into stable plaque group( n =45) and unstable plaque group( n = 35). Fifty healthy cases without atherosclerosis were selected as control group. The levels of serum MMP-9,TIMP-1 and high-sensitivity C-reactive protein( hs-CRP) were detected with automatic biochemical analyzer. Results The levels of MMP-9 and hs-CRP increased significantly while the level of TIMP-1 decreased remarkably in the simple hypertension group compared with the controls( all P 0. 05). The levels of MMP-9 and hs-CRP were significant higher while the level of TIMP-1 was significantly lower in the severe atherosclerosis group in contrast with those in the simple hypertension group and mild atherosclerosis group( P 0. 05).The levels of MMP-9 and hs-CRP increased significantly,but the levels of TIMP-1 decreased significantly in the unstable plaque group compared with stable plaque group( P 0. 05). Multivariate logistic regression analysis showed that IMT,MMP-9,TIMP-1 were the independent risk factors for hypertensive carotid atherosclerosis. Conclusion The levels of serum MMP-9 and TIMP-1 closely correlate with the formation and stability of hypertensive carotid plaque.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the relationship of matrix metalloproteinase 9( MMP-9) and tissue inhibitor of metalloproteinase 1( TIMP-1) with hypertensive carotid atherosclerosis and its stability. Methods The intima-media thickness( IMT) was measured by using color Doppler ultrasound in 125 cases of hypertension. These patients were divided into simple hypertensive group( n =45),mild atherosclerosis group( n =42) and severe atherosclerosis group( n =38) according to the results of the ultrasound diagnosis. Based on the stability of plaque in atherosclerosis patients,they were classified into stable plaque group( n =45) and unstable plaque group( n = 35). Fifty healthy cases without atherosclerosis were selected as control group. The levels of serum MMP-9,TIMP-1 and high-sensitivity C-reactive protein( hs-CRP) were detected with automatic biochemical analyzer. Results The levels of MMP-9 and hs-CRP increased significantly while the level of TIMP-1 decreased remarkably in the simple hypertension group compared with the controls( all P 0. 05). The levels of MMP-9 and hs-CRP were significant higher while the level of TIMP-1 was significantly lower in the severe atherosclerosis group in contrast with those in the simple hypertension group and mild atherosclerosis group( P 0. 05).The levels of MMP-9 and hs-CRP increased significantly,but the levels of TIMP-1 decreased significantly in the unstable plaque group compared with stable plaque group( P 0. 05). Multivariate logistic regression analysis showed that IMT,MMP-9,TIMP-1 were the independent risk factors for hypertensive carotid atherosclerosis. Conclusion The levels of serum MMP-9 and TIMP-1 closely correlate with the formation and stability of hypertensive carotid plaque.
Key concepts: Medicine, Internal medicine, Matrix metalloproteinase, Matrix metalloproteinase 9, Gastroenterology, Tissue inhibitor of metalloproteinase, Inflammation, C-reactive protein